Search filters

Filters
Clear All

Phase

  • 1
  • 1
  • 1
  • 1
  • 4
  • 4

Found 4 medicine trials

A listing of medicine medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
Test Trial for Go-Live 1 - V7.3 smoketesting
55 years - 100 years
All genders
Test Trial for Go-Live for data migration - testExclusion Criteria:The presence of any active, known, or suspected autoimmune disease. Type 1 diabetes, which was admitted to receive stable dose of insulin, hypothyroidism, which required only hormone replacement therapy, skin disease with no need to systemic treatment and no acute exacerbation …
UPCC 28922 AbatacepT foR ImmUne checkpoint inhibitor associated Myocarditis (ATRIUM): A Phase 3, Investigator-Initiated, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Compared to Placebo in Participants with Immune Checkpoint Inhibitor Associated Myocarditis
18 years or above
All genders
Phase 3
Interventional
This study investigates the effects of an investigational medication compared to a placebo in participants with myocarditis linked to immune checkpoint inhibitors (ICI). This condition can occur as a side effect of cancer treatments that use ICIs to enhance the body's immune response against cancer cells. The purpose of this …
UPCC 07623 Effect of Immune Checkpoint Inhibitors on Coronary Microvasculature
18 years or above
All genders
Observational
The purpose of this study is to investigate the effects of immune checkpoint inhibitors (ICI) on the heart and circulatory system in patients with breast cancer or non-small cell lung cancer. This study focuses on understanding how these medications, which are used in cancer treatment, might impact heart health. An …
18 years or above
All genders
Phase 2/3
Interventional
This study investigates treatments for non-small cell lung cancer (NSCLC) by using a method called genomic screening. The purpose of this study is to determine which type of cancer trait, known as a biomarker, a participant has. This information helps assign participants to different sub-studies within a larger protocol called …